Skip to main content
SpringerLink
Log in

The Need to Develop More Sensitive Tools to Accurately Detect Clinical Response to Treatment in ADHD

  • Correspondence
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazzone L, Reale L, Mannino V, et al. Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. CNS Drugs 2011; 25(6): 503–9

    Article  PubMed  Google Scholar 

  2. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001; 62 Suppl. 16: 5–9

    PubMed  CAS  Google Scholar 

  3. Busner J, Targum SD, Miller DS. The Clinical Global Impressions scale: errors in understanding and use. Compr Psychiatry 2009; 50(3): 257–62

    Article  PubMed  Google Scholar 

  4. Kadouri A, Corruble E, Falissard B. The improved Clinical Global Impression Scale (iCGI): development and validation in depression. BMC Psychiatry 2007; 7: 7

    Article  PubMed  Google Scholar 

  5. Spencer TJ, Wilens TE, Biederman J, et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2006; 28(2): 266–79

    Article  PubMed  CAS  Google Scholar 

  6. Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales: V. Scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42(9): 1015–37

    Article  PubMed  Google Scholar 

  7. Perwien AR, Kratochvil CJ, Faries DE, et al. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol 2006; 16(6): 713–24

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors declare no financial relationships with commercial interests and have no conflicts of interest. No sources of funding were used to prepare this letter.

Author information

Authors and Affiliations

  1. Department of Child Psychology, The Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China

    Rongwang Yang & Rong Li

  2. Department of Pediatrics, The First People’s Hospital of Hangzhou, Hangzhou, Zhejiang Province, China

    Shujiong Mao

  3. Department of Child Health Care, The Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China

    Zhengyan Zhao

Authors
  1. Rongwang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shujiong Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhengyan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, R., Mao, S., Li, R. et al. The Need to Develop More Sensitive Tools to Accurately Detect Clinical Response to Treatment in ADHD. CNS Drugs 26, 185–186 (2012). https://doi.org/10.2165/11630110-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11630110-000000000-00000

Keywords

Search

Navigation